IgA Fc receptors.

Area of Science:

• Immunology
• Cell Biology

Background:

• The IgA receptor family includes various surface receptors involved in IgA transport, catabolism, and deposition.
• The myeloid-specific IgA Fc receptor (FcalphaRI or CD89) is a key receptor expressed on immune cells.
• FcalphaRI lacks intrinsic signaling domains but associates with the FcR gamma-chain for activation.

Purpose of the Study:

• To review the biology of FcalphaRI (CD89).
• To elucidate the in vivo role of FcalphaRI using human FcalphaRI transgenic mice.
• To explore the implications of FcalphaRI in mucosal defense, IgA nephropathy, and disease treatment.

Main Methods:

• Review of existing literature on IgA receptors.
• Generation and utilization of human FcalphaRI transgenic (Tg) mice.
• Analysis of FcalphaRI expression and function in vivo.

Main Results:

• FcalphaRI is expressed on neutrophils, eosinophils, monocytes/macrophages, dendritic cells, and Kupffer cells.
• FcalphaRI Tg mice demonstrated FcalphaRI expression on Kupffer cells, highlighting its role in mucosal defense.
• Studies identified a role for soluble FcalphaRI in IgA nephropathy development via circulating IgA-FcalphaRI complexes.
• Recent work suggests human IgA's therapeutic potential in infectious and neoplastic diseases.

Conclusions:

• FcalphaRI is critical for antibacterial defense, particularly involving serum IgA.
• Soluble FcalphaRI is essential in the pathogenesis of IgA nephropathy.
• Human IgA and FcalphaRI hold promise for treating infectious and neoplastic diseases.